|
|
|
|
Vol. 19, Issue 6, 2520-2533, June 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
q and Cooperation between ERK1/2 and Rho Kinase Signaling Pathways
*Centre for Respiratory Research, University College London, London WC1E 6JJ, United Kingdom; and
Caden Biosciences, Madison, WI 53711
Submitted July 28, 2007;
Revised February 12, 2008;
Accepted March 6, 2008
Monitoring Editor: Mark Ginsberg
Uncontrolled activation of the coagulation cascade after tissue injury has been implicated in both inflammation and tissue fibrosis. Thrombin exerts pluripotent cellular effects via its high-affinity receptor, proteinase-activated receptor-1 (PAR1) and signaling via G
i/o, G
q, or G
12/13. Activation of PAR1 on fibroblasts, a key effector cell in fibrosis, results in the induction of several mediators, including the potent monocyte and fibrocyte chemoattractant CCL2. The aim of this study was to identify the G protein and signaling pathway involved in PAR1-mediated CCL2 production and release. Using a novel PAR1 antagonist that blocks the interaction between PAR1 and G
q, we report for the first time that PAR1 coupling to G
q is essential for thrombin-induced CCL2 gene expression and protein release in murine lung fibroblasts. We further demonstrate that these effects are mediated via the cooperation between ERK1/2 and Rho kinase signaling pathways: a calcium-independent protein kinase C (PKC), c-Raf, and ERK1/2 pathway was found to mediate PAR1-induced CCL2 gene transcription, whereas a phospholipase C, calcium-dependent PKC, and Rho kinase pathway influences CCL2 protein release. We propose that targeting the interaction between PAR1 and G
q may allow us to selectively interfere with PAR1 proinflammatory and profibrotic signaling, while preserving the essential role of other PAR1-mediated cellular responses.
Address correspondence to: Rachel C. Chambers (r.chambers{at}ucl.ac.uk).
Abbreviations used: ARDS, acute respiratory distress syndrome; BALF, bronchoalveolar lavage fluid; ca-MEK1, constitutively active MEK1; dn-MEK1, dominant negative-MEK1; EGFP, enhanced green fluorescent protein; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; KO, knockout; MLF, mouse lung fibroblast; PAR, proteinase-activated receptor; wt-MEK1, wild-type MEK1.
This article has been cited by other articles:
![]() |
G. J Allan, J. Beattie, and D. J Flint Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5 J. Endocrinol., November 1, 2008; 199(2): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, A. Carpenter, J. Abrahams, R. C. Chambers, R. I. Lechler, J. H. McVey, and A. Dorling Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo J. Exp. Med., August 4, 2008; 205(8): 1739 - 1746. [Abstract] [Full Text] [PDF] |
||||